0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cystic Fibrosis (CF) Therapeutics Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-23F12930
Home | Market Reports | Health| Health Conditions
Global Cystic Fibrosis CF Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Cystic Fibrosis (CF) Therapeutics Market Research Report 2024

Code: QYRE-Auto-23F12930
Report
May 2024
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cystic Fibrosis (CF) Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Cystic Fibrosis (CF) Therapeutics Market

Cystic Fibrosis (CF) Therapeutics Market

Cystic fibrosis is a genetic disease that causes continuous lung infections and breathing problem over time. It is a progressive disease. The presence of imperfect gene causes a thick, sticky buildup of mucus in the lungs, intestine liver, pancreas, and other organs. The mucus in the lungs clogs airways and traps bacteria leading to infections that causes savior lung damage, and respiratory failure. The mucus prevents in the pancreas discharge the digestive enzymes that allow the body to break down food and absorb vital nutrients. This disease is caused by mutation in gene, cystic fibrosis trans membrane conductance regulator (CFTR) is a membrane protein in vertebrates, a protein required for regulating sweat, mucus and body secretions.
The global Cystic Fibrosis (CF) Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cystic Fibrosis (CF) Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cystic Fibrosis (CF) Therapeutics.

Report Scope

The Cystic Fibrosis (CF) Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cystic Fibrosis (CF) Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cystic Fibrosis (CF) Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cystic Fibrosis (CF) Therapeutics Market Report

Report Metric Details
Report Name Cystic Fibrosis (CF) Therapeutics Market
CAGR 5%
Segment by Type
  • Pancreatic enzyme supplements
  • Mucolytics
  • Bronchodilators
  • CFTR modulators
Segment by Application
  • Oral drugs
  • Inhaled drugs
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Vertex Pharmaceuticalsorporated, Gilead, AbbVie,, Novartis AG, F. Hoffmann-La Roche Ltd, Alaxia, Merck & Co., AIT (Advanced Inhalation Therapies), ALLERGAN, AstraZeneca, Teva Pharmaceutical Industries Ltd, Alcresta
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cystic Fibrosis (CF) Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cystic Fibrosis (CF) Therapeutics Market report?

Ans: The main players in the Cystic Fibrosis (CF) Therapeutics Market are Vertex Pharmaceuticalsorporated, Gilead, AbbVie,, Novartis AG, F. Hoffmann-La Roche Ltd, Alaxia, Merck & Co., AIT (Advanced Inhalation Therapies), ALLERGAN, AstraZeneca, Teva Pharmaceutical Industries Ltd, Alcresta

What are the Application segmentation covered in the Cystic Fibrosis (CF) Therapeutics Market report?

Ans: The Applications covered in the Cystic Fibrosis (CF) Therapeutics Market report are Oral drugs, Inhaled drugs

What are the Type segmentation covered in the Cystic Fibrosis (CF) Therapeutics Market report?

Ans: The Types covered in the Cystic Fibrosis (CF) Therapeutics Market report are Pancreatic enzyme supplements, Mucolytics, Bronchodilators, CFTR modulators

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Pancreatic enzyme supplements
1.2.3 Mucolytics
1.2.4 Bronchodilators
1.2.5 CFTR modulators
1.3 Market by Application
1.3.1 Global Cystic Fibrosis (CF) Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oral drugs
1.3.3 Inhaled drugs
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cystic Fibrosis (CF) Therapeutics Market Perspective (2019-2030)
2.2 Cystic Fibrosis (CF) Therapeutics Growth Trends by Region
2.2.1 Global Cystic Fibrosis (CF) Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cystic Fibrosis (CF) Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Cystic Fibrosis (CF) Therapeutics Market Dynamics
2.3.1 Cystic Fibrosis (CF) Therapeutics Industry Trends
2.3.2 Cystic Fibrosis (CF) Therapeutics Market Drivers
2.3.3 Cystic Fibrosis (CF) Therapeutics Market Challenges
2.3.4 Cystic Fibrosis (CF) Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cystic Fibrosis (CF) Therapeutics Players by Revenue
3.1.1 Global Top Cystic Fibrosis (CF) Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Cystic Fibrosis (CF) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cystic Fibrosis (CF) Therapeutics Revenue
3.4 Global Cystic Fibrosis (CF) Therapeutics Market Concentration Ratio
3.4.1 Global Cystic Fibrosis (CF) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cystic Fibrosis (CF) Therapeutics Revenue in 2023
3.5 Cystic Fibrosis (CF) Therapeutics Key Players Head office and Area Served
3.6 Key Players Cystic Fibrosis (CF) Therapeutics Product Solution and Service
3.7 Date of Enter into Cystic Fibrosis (CF) Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cystic Fibrosis (CF) Therapeutics Breakdown Data by Type
4.1 Global Cystic Fibrosis (CF) Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Type (2025-2030)
5 Cystic Fibrosis (CF) Therapeutics Breakdown Data by Application
5.1 Global Cystic Fibrosis (CF) Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cystic Fibrosis (CF) Therapeutics Market Size (2019-2030)
6.2 North America Cystic Fibrosis (CF) Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2019-2024)
6.4 North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cystic Fibrosis (CF) Therapeutics Market Size (2019-2030)
7.2 Europe Cystic Fibrosis (CF) Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2019-2024)
7.4 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cystic Fibrosis (CF) Therapeutics Market Size (2019-2030)
9.2 Latin America Cystic Fibrosis (CF) Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Vertex Pharmaceuticalsorporated
11.1.1 Vertex Pharmaceuticalsorporated Company Detail
11.1.2 Vertex Pharmaceuticalsorporated Business Overview
11.1.3 Vertex Pharmaceuticalsorporated Cystic Fibrosis (CF) Therapeutics Introduction
11.1.4 Vertex Pharmaceuticalsorporated Revenue in Cystic Fibrosis (CF) Therapeutics Business (2019-2024)
11.1.5 Vertex Pharmaceuticalsorporated Recent Development
11.2 Gilead
11.2.1 Gilead Company Detail
11.2.2 Gilead Business Overview
11.2.3 Gilead Cystic Fibrosis (CF) Therapeutics Introduction
11.2.4 Gilead Revenue in Cystic Fibrosis (CF) Therapeutics Business (2019-2024)
11.2.5 Gilead Recent Development
11.3 AbbVie,
11.3.1 AbbVie, Company Detail
11.3.2 AbbVie, Business Overview
11.3.3 AbbVie, Cystic Fibrosis (CF) Therapeutics Introduction
11.3.4 AbbVie, Revenue in Cystic Fibrosis (CF) Therapeutics Business (2019-2024)
11.3.5 AbbVie, Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Detail
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Cystic Fibrosis (CF) Therapeutics Introduction
11.4.4 Novartis AG Revenue in Cystic Fibrosis (CF) Therapeutics Business (2019-2024)
11.4.5 Novartis AG Recent Development
11.5 F. Hoffmann-La Roche Ltd
11.5.1 F. Hoffmann-La Roche Ltd Company Detail
11.5.2 F. Hoffmann-La Roche Ltd Business Overview
11.5.3 F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Introduction
11.5.4 F. Hoffmann-La Roche Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2019-2024)
11.5.5 F. Hoffmann-La Roche Ltd Recent Development
11.6 Alaxia
11.6.1 Alaxia Company Detail
11.6.2 Alaxia Business Overview
11.6.3 Alaxia Cystic Fibrosis (CF) Therapeutics Introduction
11.6.4 Alaxia Revenue in Cystic Fibrosis (CF) Therapeutics Business (2019-2024)
11.6.5 Alaxia Recent Development
11.7 Merck & Co.
11.7.1 Merck & Co. Company Detail
11.7.2 Merck & Co. Business Overview
11.7.3 Merck & Co. Cystic Fibrosis (CF) Therapeutics Introduction
11.7.4 Merck & Co. Revenue in Cystic Fibrosis (CF) Therapeutics Business (2019-2024)
11.7.5 Merck & Co. Recent Development
11.8 AIT (Advanced Inhalation Therapies)
11.8.1 AIT (Advanced Inhalation Therapies) Company Detail
11.8.2 AIT (Advanced Inhalation Therapies) Business Overview
11.8.3 AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Introduction
11.8.4 AIT (Advanced Inhalation Therapies) Revenue in Cystic Fibrosis (CF) Therapeutics Business (2019-2024)
11.8.5 AIT (Advanced Inhalation Therapies) Recent Development
11.9 ALLERGAN
11.9.1 ALLERGAN Company Detail
11.9.2 ALLERGAN Business Overview
11.9.3 ALLERGAN Cystic Fibrosis (CF) Therapeutics Introduction
11.9.4 ALLERGAN Revenue in Cystic Fibrosis (CF) Therapeutics Business (2019-2024)
11.9.5 ALLERGAN Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Detail
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Cystic Fibrosis (CF) Therapeutics Introduction
11.10.4 AstraZeneca Revenue in Cystic Fibrosis (CF) Therapeutics Business (2019-2024)
11.10.5 AstraZeneca Recent Development
11.11 Teva Pharmaceutical Industries Ltd
11.11.1 Teva Pharmaceutical Industries Ltd Company Detail
11.11.2 Teva Pharmaceutical Industries Ltd Business Overview
11.11.3 Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Introduction
11.11.4 Teva Pharmaceutical Industries Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2019-2024)
11.11.5 Teva Pharmaceutical Industries Ltd Recent Development
11.12 Alcresta
11.12.1 Alcresta Company Detail
11.12.2 Alcresta Business Overview
11.12.3 Alcresta Cystic Fibrosis (CF) Therapeutics Introduction
11.12.4 Alcresta Revenue in Cystic Fibrosis (CF) Therapeutics Business (2019-2024)
11.12.5 Alcresta Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Pancreatic enzyme supplements
    Table 3. Key Players of Mucolytics
    Table 4. Key Players of Bronchodilators
    Table 5. Key Players of CFTR modulators
    Table 6. Global Cystic Fibrosis (CF) Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Cystic Fibrosis (CF) Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Cystic Fibrosis (CF) Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Cystic Fibrosis (CF) Therapeutics Market Share by Region (2019-2024)
    Table 10. Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Cystic Fibrosis (CF) Therapeutics Market Share by Region (2025-2030)
    Table 12. Cystic Fibrosis (CF) Therapeutics Market Trends
    Table 13. Cystic Fibrosis (CF) Therapeutics Market Drivers
    Table 14. Cystic Fibrosis (CF) Therapeutics Market Challenges
    Table 15. Cystic Fibrosis (CF) Therapeutics Market Restraints
    Table 16. Global Cystic Fibrosis (CF) Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Cystic Fibrosis (CF) Therapeutics Market Share by Players (2019-2024)
    Table 18. Global Top Cystic Fibrosis (CF) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis (CF) Therapeutics as of 2023)
    Table 19. Ranking of Global Top Cystic Fibrosis (CF) Therapeutics Companies by Revenue (US$ Million) in 2023
    Table 20. Global 5 Largest Players Market Share by Cystic Fibrosis (CF) Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Cystic Fibrosis (CF) Therapeutics Product Solution and Service
    Table 23. Date of Enter into Cystic Fibrosis (CF) Therapeutics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Cystic Fibrosis (CF) Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Type (2019-2024)
    Table 27. Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Type (2025-2030)
    Table 29. Global Cystic Fibrosis (CF) Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Application (2019-2024)
    Table 31. Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Application (2025-2030)
    Table 33. North America Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 34. North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 35. North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 36. Europe Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 38. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 40. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 41. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 42. Latin America Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 48. Vertex Pharmaceuticalsorporated Company Detail
    Table 49. Vertex Pharmaceuticalsorporated Business Overview
    Table 50. Vertex Pharmaceuticalsorporated Cystic Fibrosis (CF) Therapeutics Product
    Table 51. Vertex Pharmaceuticalsorporated Revenue in Cystic Fibrosis (CF) Therapeutics Business (2019-2024) & (US$ Million)
    Table 52. Vertex Pharmaceuticalsorporated Recent Development
    Table 53. Gilead Company Detail
    Table 54. Gilead Business Overview
    Table 55. Gilead Cystic Fibrosis (CF) Therapeutics Product
    Table 56. Gilead Revenue in Cystic Fibrosis (CF) Therapeutics Business (2019-2024) & (US$ Million)
    Table 57. Gilead Recent Development
    Table 58. AbbVie, Company Detail
    Table 59. AbbVie, Business Overview
    Table 60. AbbVie, Cystic Fibrosis (CF) Therapeutics Product
    Table 61. AbbVie, Revenue in Cystic Fibrosis (CF) Therapeutics Business (2019-2024) & (US$ Million)
    Table 62. AbbVie, Recent Development
    Table 63. Novartis AG Company Detail
    Table 64. Novartis AG Business Overview
    Table 65. Novartis AG Cystic Fibrosis (CF) Therapeutics Product
    Table 66. Novartis AG Revenue in Cystic Fibrosis (CF) Therapeutics Business (2019-2024) & (US$ Million)
    Table 67. Novartis AG Recent Development
    Table 68. F. Hoffmann-La Roche Ltd Company Detail
    Table 69. F. Hoffmann-La Roche Ltd Business Overview
    Table 70. F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Product
    Table 71. F. Hoffmann-La Roche Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2019-2024) & (US$ Million)
    Table 72. F. Hoffmann-La Roche Ltd Recent Development
    Table 73. Alaxia Company Detail
    Table 74. Alaxia Business Overview
    Table 75. Alaxia Cystic Fibrosis (CF) Therapeutics Product
    Table 76. Alaxia Revenue in Cystic Fibrosis (CF) Therapeutics Business (2019-2024) & (US$ Million)
    Table 77. Alaxia Recent Development
    Table 78. Merck & Co. Company Detail
    Table 79. Merck & Co. Business Overview
    Table 80. Merck & Co. Cystic Fibrosis (CF) Therapeutics Product
    Table 81. Merck & Co. Revenue in Cystic Fibrosis (CF) Therapeutics Business (2019-2024) & (US$ Million)
    Table 82. Merck & Co. Recent Development
    Table 83. AIT (Advanced Inhalation Therapies) Company Detail
    Table 84. AIT (Advanced Inhalation Therapies) Business Overview
    Table 85. AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Product
    Table 86. AIT (Advanced Inhalation Therapies) Revenue in Cystic Fibrosis (CF) Therapeutics Business (2019-2024) & (US$ Million)
    Table 87. AIT (Advanced Inhalation Therapies) Recent Development
    Table 88. ALLERGAN Company Detail
    Table 89. ALLERGAN Business Overview
    Table 90. ALLERGAN Cystic Fibrosis (CF) Therapeutics Product
    Table 91. ALLERGAN Revenue in Cystic Fibrosis (CF) Therapeutics Business (2019-2024) & (US$ Million)
    Table 92. ALLERGAN Recent Development
    Table 93. AstraZeneca Company Detail
    Table 94. AstraZeneca Business Overview
    Table 95. AstraZeneca Cystic Fibrosis (CF) Therapeutics Product
    Table 96. AstraZeneca Revenue in Cystic Fibrosis (CF) Therapeutics Business (2019-2024) & (US$ Million)
    Table 97. AstraZeneca Recent Development
    Table 98. Teva Pharmaceutical Industries Ltd Company Detail
    Table 99. Teva Pharmaceutical Industries Ltd Business Overview
    Table 100. Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Product
    Table 101. Teva Pharmaceutical Industries Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2019-2024) & (US$ Million)
    Table 102. Teva Pharmaceutical Industries Ltd Recent Development
    Table 103. Alcresta Company Detail
    Table 104. Alcresta Business Overview
    Table 105. Alcresta Cystic Fibrosis (CF) Therapeutics Product
    Table 106. Alcresta Revenue in Cystic Fibrosis (CF) Therapeutics Business (2019-2024) & (US$ Million)
    Table 107. Alcresta Recent Development
    Table 108. Research Programs/Design for This Report
    Table 109. Key Data Information from Secondary Sources
    Table 110. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cystic Fibrosis (CF) Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Cystic Fibrosis (CF) Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. Pancreatic enzyme supplements Features
    Figure 4. Mucolytics Features
    Figure 5. Bronchodilators Features
    Figure 6. CFTR modulators Features
    Figure 7. Global Cystic Fibrosis (CF) Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Cystic Fibrosis (CF) Therapeutics Market Share by Application: 2023 VS 2030
    Figure 9. Oral drugs Case Studies
    Figure 10. Inhaled drugs Case Studies
    Figure 11. Cystic Fibrosis (CF) Therapeutics Report Years Considered
    Figure 12. Global Cystic Fibrosis (CF) Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Cystic Fibrosis (CF) Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Cystic Fibrosis (CF) Therapeutics Market Share by Region: 2023 VS 2030
    Figure 15. Global Cystic Fibrosis (CF) Therapeutics Market Share by Players in 2023
    Figure 16. Global Top Cystic Fibrosis (CF) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis (CF) Therapeutics as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Cystic Fibrosis (CF) Therapeutics Revenue in 2023
    Figure 18. North America Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Cystic Fibrosis (CF) Therapeutics Market Share by Country (2019-2030)
    Figure 20. United States Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Canada Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Cystic Fibrosis (CF) Therapeutics Market Share by Country (2019-2030)
    Figure 24. Germany Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. France Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. U.K. Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Italy Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Russia Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Nordic Countries Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Share by Region (2019-2030)
    Figure 32. China Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Japan Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. South Korea Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Southeast Asia Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. India Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Australia Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Cystic Fibrosis (CF) Therapeutics Market Share by Country (2019-2030)
    Figure 40. Mexico Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Brazil Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Share by Country (2019-2030)
    Figure 44. Turkey Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Saudi Arabia Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Vertex Pharmaceuticalsorporated Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2019-2024)
    Figure 47. Gilead Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2019-2024)
    Figure 48. AbbVie, Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2019-2024)
    Figure 49. Novartis AG Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2019-2024)
    Figure 50. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2019-2024)
    Figure 51. Alaxia Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2019-2024)
    Figure 52. Merck & Co. Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2019-2024)
    Figure 53. AIT (Advanced Inhalation Therapies) Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2019-2024)
    Figure 54. ALLERGAN Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2019-2024)
    Figure 55. AstraZeneca Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2019-2024)
    Figure 56. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2019-2024)
    Figure 57. Alcresta Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2019-2024)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Blood Pressure Mointor Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-35U11386
Thu Jun 20 00:00:00 UTC 2024

Add to Cart

Global Isosorbide Mononitrate and Glucose Injection Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-8U11347
Wed Jun 19 00:00:00 UTC 2024

Add to Cart

Global Automatic Blood Sugar Monitor Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-21E11553
Wed Jun 19 00:00:00 UTC 2024

Add to Cart

Global Closed Chest Drainage Bag Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-5M12588
Tue Jun 18 00:00:00 UTC 2024

Add to Cart